Nanomedicine - Nanoparticles, molecular biosensors and targeted gene/drug delivery for combined single-cell diagnostics and therapeutics

Tarl W. Prow; Jose H. Salazar; William A. Rose; Jacob N. Smith; Lisa Reece; Andrea A. Fontenot; Nan A. Wang; R. Stephen Lloyd; James F. Leary

doi:10.1117/12.547922

Nanomedicine - Nanoparticles, molecular biosensors and targeted gene/drug delivery for combined single-cell diagnostics and therapeutics

Tarl W. Prow, Jose H. Salazar, William A. Rose, Jacob N. Smith, Lisa Reece, Andrea A. Fontenot, Nan A. Wang, R. Stephen Lloyd, James F. Leary

Clinical Laboratory Sciences

Research output: Contribution to journal › Conference article › peer-review

14 Scopus citations

Abstract

The next generation nanomedicine technologies to provide single-cell diagnostics and therapeutics were discussed. These technologies employs a cell-by-cell regenerative and repair philosophy working at the single cell level rather than at the organ level. Nanomedicine performs nanosurgery inside living cells and either perform repairs or induce those cells to die through apoptosis. The ultimate aim of the nanomedicine was to combine diagnostics and therapeutics into real-time medicine, using where possible in-vivo cytometry techniques for diagnostics and therapeutics.

Original language	English (US)
Pages (from-to)	1-11
Number of pages	11
Journal	Proceedings of SPIE - The International Society for Optical Engineering
Volume	5318
DOIs	https://doi.org/10.1117/12.547922
State	Published - 2004
Event	Progress in Biomedical Optics and Imaging - Adavnced Biomedical and Clinical Diagnostic Systems II - San Jose, CA, United States Duration: Jan 25 2004 → Jan 26 2004

Keywords

Drug delivery
Gene therapy; flow cytometry; confocal microscopy; molecular diagnostics
Molecular biosensors
Nanomedicine; nanoparticles

ASJC Scopus subject areas

Electronic, Optical and Magnetic Materials
Condensed Matter Physics
Computer Science Applications
Applied Mathematics
Electrical and Electronic Engineering

Access to Document

10.1117/12.547922

Cite this

Prow, T. W., Salazar, J. H., Rose, W. A., Smith, J. N., Reece, L., Fontenot, A. A., Wang, N. A., Lloyd, R. S., & Leary, J. F. (2004). Nanomedicine - Nanoparticles, molecular biosensors and targeted gene/drug delivery for combined single-cell diagnostics and therapeutics. Proceedings of SPIE - The International Society for Optical Engineering, 5318, 1-11. https://doi.org/10.1117/12.547922

Nanomedicine - Nanoparticles, molecular biosensors and targeted gene/drug delivery for combined single-cell diagnostics and therapeutics. / Prow, Tarl W.; Salazar, Jose H.; Rose, William A. et al.
In: Proceedings of SPIE - The International Society for Optical Engineering, Vol. 5318, 2004, p. 1-11.

Research output: Contribution to journal › Conference article › peer-review

Prow, TW, Salazar, JH, Rose, WA, Smith, JN, Reece, L, Fontenot, AA, Wang, NA, Lloyd, RS & Leary, JF 2004, 'Nanomedicine - Nanoparticles, molecular biosensors and targeted gene/drug delivery for combined single-cell diagnostics and therapeutics', Proceedings of SPIE - The International Society for Optical Engineering, vol. 5318, pp. 1-11. https://doi.org/10.1117/12.547922

@article{f438bb619bce43f1baf0341b923d035f,

title = "Nanomedicine - Nanoparticles, molecular biosensors and targeted gene/drug delivery for combined single-cell diagnostics and therapeutics",

abstract = "The next generation nanomedicine technologies to provide single-cell diagnostics and therapeutics were discussed. These technologies employs a cell-by-cell regenerative and repair philosophy working at the single cell level rather than at the organ level. Nanomedicine performs nanosurgery inside living cells and either perform repairs or induce those cells to die through apoptosis. The ultimate aim of the nanomedicine was to combine diagnostics and therapeutics into real-time medicine, using where possible in-vivo cytometry techniques for diagnostics and therapeutics.",

keywords = "Drug delivery, Gene therapy; flow cytometry; confocal microscopy; molecular diagnostics, Molecular biosensors, Nanomedicine; nanoparticles",

author = "Prow, {Tarl W.} and Salazar, {Jose H.} and Rose, {William A.} and Smith, {Jacob N.} and Lisa Reece and Fontenot, {Andrea A.} and Wang, {Nan A.} and Lloyd, {R. Stephen} and Leary, {James F.}",

year = "2004",

doi = "10.1117/12.547922",

language = "English (US)",

volume = "5318",

pages = "1--11",

journal = "Proceedings of SPIE - The International Society for Optical Engineering",

issn = "0277-786X",

publisher = "SPIE",

note = "Progress in Biomedical Optics and Imaging - Adavnced Biomedical and Clinical Diagnostic Systems II ; Conference date: 25-01-2004 Through 26-01-2004",

}

TY - JOUR

T1 - Nanomedicine - Nanoparticles, molecular biosensors and targeted gene/drug delivery for combined single-cell diagnostics and therapeutics

AU - Prow, Tarl W.

AU - Salazar, Jose H.

AU - Rose, William A.

AU - Smith, Jacob N.

AU - Reece, Lisa

AU - Fontenot, Andrea A.

AU - Wang, Nan A.

AU - Lloyd, R. Stephen

AU - Leary, James F.

PY - 2004

Y1 - 2004

N2 - The next generation nanomedicine technologies to provide single-cell diagnostics and therapeutics were discussed. These technologies employs a cell-by-cell regenerative and repair philosophy working at the single cell level rather than at the organ level. Nanomedicine performs nanosurgery inside living cells and either perform repairs or induce those cells to die through apoptosis. The ultimate aim of the nanomedicine was to combine diagnostics and therapeutics into real-time medicine, using where possible in-vivo cytometry techniques for diagnostics and therapeutics.

AB - The next generation nanomedicine technologies to provide single-cell diagnostics and therapeutics were discussed. These technologies employs a cell-by-cell regenerative and repair philosophy working at the single cell level rather than at the organ level. Nanomedicine performs nanosurgery inside living cells and either perform repairs or induce those cells to die through apoptosis. The ultimate aim of the nanomedicine was to combine diagnostics and therapeutics into real-time medicine, using where possible in-vivo cytometry techniques for diagnostics and therapeutics.

KW - Drug delivery

KW - Gene therapy; flow cytometry; confocal microscopy; molecular diagnostics

KW - Molecular biosensors

KW - Nanomedicine; nanoparticles

UR - http://www.scopus.com/inward/record.url?scp=5644301120&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=5644301120&partnerID=8YFLogxK

U2 - 10.1117/12.547922

DO - 10.1117/12.547922

M3 - Conference article

AN - SCOPUS:5644301120

SN - 0277-786X

VL - 5318

SP - 1

EP - 11

JO - Proceedings of SPIE - The International Society for Optical Engineering

JF - Proceedings of SPIE - The International Society for Optical Engineering

T2 - Progress in Biomedical Optics and Imaging - Adavnced Biomedical and Clinical Diagnostic Systems II

Y2 - 25 January 2004 through 26 January 2004

ER -

Nanomedicine - Nanoparticles, molecular biosensors and targeted gene/drug delivery for combined single-cell diagnostics and therapeutics

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this